Patents by Inventor Kazuto FUKUNAGA

Kazuto FUKUNAGA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240017267
    Abstract: A pulverizing method comprising: pulverizing a polymer porous body; and removing electricity from the polymer porous body during the pulverization. A method for producing a polymer block, comprising: pulverizing a polymer porous body; and removing electricity from the polymer porous body during the pulverization. A pulverization device comprising: a pulverizing portion which pulverizes a polymer porous body; and an irradiating portion which irradiates at least a part of the pulverizing portion with a radiation, wherein electricity is removed from the polymer porous body during the pulverization in the pulverizing portion by the radiation radiated from the irradiating portion.
    Type: Application
    Filed: September 29, 2023
    Publication date: January 18, 2024
    Applicant: FUJIFILM Corporation
    Inventors: Kazuto FUKUNAGA, Nobuhiko KATO
  • Publication number: 20230377764
    Abstract: The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the disclosure relate to a composition comprising an immunotherapeutic antibody operatively linked to an extracellular matrix (ECM)-affinity peptide. An ECM-affinity peptide is one that has affinity for an extracellular matrix protein.
    Type: Application
    Filed: February 3, 2023
    Publication date: November 23, 2023
    Applicant: The University of Chicago
    Inventors: Jeffrey A. HUBBELL, Jun ISHIHARA, Ako ISHIHARA, Kazuto FUKUNAGA, Melody SWARTZ
  • Patent number: 11574747
    Abstract: The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the disclosure relate to a composition comprising an immunotherapeutic antibody operatively linked to an extracellular matrix (ECM)-affinity peptide. An ECM-affinity peptide is one that has affinity for an extracellular matrix protein.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: February 7, 2023
    Assignee: The University of Chicago
    Inventors: Jeffrey A. Hubbell, Jun Ishihara, Ako Ishihara, Kazuto Fukunaga, Melody Swartz
  • Publication number: 20200123228
    Abstract: The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the disclosure relate to a composition comprising an immunotherapeutic antibody operatively linked to an extracellular matrix (ECM)-affinity peptide. An ECM-affinity peptide is one that has affinity for an extracellular matrix protein.
    Type: Application
    Filed: April 20, 2018
    Publication date: April 23, 2020
    Inventors: Jeffrey A. HUBBELL, Jun ISHIHARA, Ako ISHIHARA, Kazuto FUKUNAGA, Melody SWARTZ